{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:13:57Z","timestamp":1777281237536,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107784","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:29:31Z","timestamp":1777278571000},"source":"Crossref","is-referenced-by-count":0,"title":["Brainstem Encephalitis With Conflicting Autoimmune and Infectious Markers: A Case Report"],"prefix":"10.7759","author":[{"given":"Ismail","family":"Yuce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa E","family":"Tavsanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26094455","article-title":"Fluid biomarkers in demyelinating spectrum disorders: past, present, and prospects","volume":"26","author":"Florea AM","year":"2025","unstructured":"Florea AM, Nea\u021bu M, Luca DG, Davidescu EI, Popescu BO. Fluid biomarkers in demyelinating spectrum disorders: past, present, and prospects. Int J Mol Sci. 2025, 26:4455. 10.3390\/ijms26094455","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1358599","article-title":"Rare inflammatory diseases of the white matter and mimics of multiple sclerosis and related disorders","volume":"44","author":"Tardieu M","year":"2013","unstructured":"Tardieu M, Deiva K. Rare inflammatory diseases of the white matter and mimics of multiple sclerosis and related disorders. Neuropediatrics. 2013, 44:302-8. 10.1055\/s-0033-1358599","journal-title":"Neuropediatrics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.898049","article-title":"Differentiating central nervous system demyelinating disorders: the role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity","volume":"13","author":"Karathanasis DK","year":"2022","unstructured":"Karathanasis DK, Rapti A, Nezos A, Skarlis C, Kilidireas C, Mavragani CP, Evangelopoulos ME. Differentiating central nervous system demyelinating disorders: the role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity. Front Pharmacol. 2022, 13:898049. 10.3389\/fphar.2022.898049","journal-title":"Front Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban X","year":"2024","unstructured":"Montalban X, Lebrun-Fr\u00e9nay C, Oh J, et al.. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet. 2024, 24:850-65. 10.1016\/S1474-4422(25)00270-4","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-JVATITD-2020-0011","article-title":"Inflammatory lesions and brain tumors: is it possible to differentiate them based on texture features in magnetic resonance imaging?","volume":"26","author":"Alves AF","year":"2020","unstructured":"Alves AF, Miranda JR, Reis F, et al.. Inflammatory lesions and brain tumors: is it possible to differentiate them based on texture features in magnetic resonance imaging?. J Venom Anim Toxins Incl Trop Dis. 2020, 26:e20200011. 10.1590\/1678-9199-JVATITD-2020-0011","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05127.x","article-title":"Epitope specificity and significance in systemic autoimmune diseases","volume":"1183","author":"Mahler M","year":"2010","unstructured":"Mahler M, Fritzler MJ. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci. 2010, 1183:267-87. 10.1111\/j.1749-6632.2009.05127.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2011.06.041","article-title":"Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA","volume":"412","author":"Mahler M","year":"2011","unstructured":"Mahler M, You D, Baron M, Taillefer SS, Hudson M, Fritzler MJ. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA. Clin Chim Acta. 2011, 412:1937-43. 10.1016\/j.cca.2011.06.041","journal-title":"Clin Chim Acta"},{"key":"ref8","article-title":"The role of anti-CENP-B and anti-SS-B antibodies in breast cancer","volume":"52","author":"Atalay C","year":"2005","unstructured":"Atalay C, Atalay G, Yilmaz KB, Altinok M. The role of anti-CENP-B and anti-SS-B antibodies in breast cancer. Neoplasma. 2005, 52:32-5.","journal-title":"Neoplasma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jmp2040024","article-title":"Clinical and molecular features of anti-CENP-B autoantibodies","volume":"2","author":"Prasad RM","year":"2021","unstructured":"Prasad RM, Bellacosa A, Yen TJ. Clinical and molecular features of anti-CENP-B autoantibodies. J Mol Pathol. 2021, 2:281-95. 10.3390\/jmp2040024","journal-title":"J Mol Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu G","year":"2019","unstructured":"Sotgiu G, Saderi L, Petruccioli E, Aliberti S, Piana A, Petrone L, Goletti D. QuantiFERON TB gold plus for the diagnosis of tuberculosis: a systematic review and meta-analysis. J Infect. 2019, 79:444-53. 10.1016\/j.jinf.2019.08.018","journal-title":"J Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201508-532OC","article-title":"Cumulative false-positive QuantiFERON-TB interferon-\u03b3 release assay results","volume":"13","author":"Gamsky TE","year":"2016","unstructured":"Gamsky TE, Lum T, Hung-Fan M, Green JA. Cumulative false-positive QuantiFERON-TB interferon-\u03b3 release assay results. Ann Am Thorac Soc. 2016, 13:660-5. 10.1513\/AnnalsATS.201508-532OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002606","article-title":"False-positive results of Quantiferon-Tb-gold assay in children","volume":"39","author":"Quintana-Ortega C","year":"2020","unstructured":"Quintana-Ortega C, Mendez-Echevarria A, Del Rosal T, Gonzalez-Mu\u00f1oz M, Baquero-Artigao F. False-positive results of Quantiferon-Tb-gold assay in children. Pediatr Infect Dis J. 2020, 39:620-3. 10.1097\/INF.0000000000002606","journal-title":"Pediatr Infect Dis J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-008-9789-9","article-title":"Cerebral astroblastoma: analysis of six cases and critical review of treatment options","volume":"93","author":"Salvati M","year":"2009","unstructured":"Salvati M, D'Elia A, Brogna C, et al.. Cerebral astroblastoma: analysis of six cases and critical review of treatment options. J Neurooncol. 2009, 93:369-78. 10.1007\/s11060-008-9789-9","journal-title":"J Neurooncol"},{"key":"ref14","article-title":"World Health Organization classification of tumors of the central nervous system 5(th) Edition (WHO CNS5): What's new?","volume":"65","author":"Mahajan S","year":"2022","unstructured":"Mahajan S, Suri V, Sahu S, Sharma MC, Sarkar C. World Health Organization classification of tumors of the central nervous system 5(th) Edition (WHO CNS5): What's new?. Indian J Pathol Microbiol. 2022, 65:S5-13.","journal-title":"Indian J Pathol Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6815","article-title":"Imaging review of paraneoplastic neurologic syndromes","volume":"41","author":"Madhavan AA","year":"2020","unstructured":"Madhavan AA, Carr CM, Morris PP, et al.. Imaging review of paraneoplastic neurologic syndromes. AJNR Am J Neuroradiol. 2020, 41:2176-87. 10.3174\/ajnr.A6815","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2015.0189","article-title":"Rhombencephalitis: pictorial essay","volume":"49","author":"Campos LG","year":"2016","unstructured":"Campos LG, Trindade RA, Faistauer \u00c2, P\u00e9rez JA, Vedolin LM, Duarte J\u00c1. Rhombencephalitis: pictorial essay. Radiol Bras. 2016, 49:329-36. 10.1590\/0100-3984.2015.0189","journal-title":"Radiol Bras"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-011-0228-5","article-title":"Rhombencephalitis \/ brainstem encephalitis","volume":"11","author":"Jubelt B","year":"2011","unstructured":"Jubelt B, Mihai C, Li TM, Veerapaneni P. Rhombencephalitis \/ brainstem encephalitis. Curr Neurol Neurosci Rep. 2011, 11:543-52. 10.1007\/s11910-011-0228-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5114\/fn.2026.158745","article-title":"Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination","volume":"64","author":"Mehmood A","year":"2026","unstructured":"Mehmood A, Din M, Munawer M, Shah SK, Liu X, Jiang H, Wang X. Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination. Folia Neuropathol. 2026, 64:63-72. 10.5114\/fn.2026.158745","journal-title":"Folia Neuropathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2025.152369","article-title":"LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING\/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition","volume":"29","author":"Mehmood A","year":"2025","unstructured":"Mehmood A, Xue YZ, Yassin HM, Zubair M, Rahmat SA, Ahmad A. LINE-1 retrotransposon activation drives age-associated inflammation via cytoplasmic cDNA-STING\/type I interferon signalling: therapeutic potential of reverse transcriptase inhibition. Contemp Oncol (Pozn). 2025, 29:240-6. 10.5114\/wo.2025.152369","journal-title":"Contemp Oncol (Pozn)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-04588-5","article-title":"BTK and YKL-40 levels and their association with acute AQP4-IgG-positive neuromyelitis optica spectrum disorder","volume":"62","author":"Liu J","year":"2025","unstructured":"Liu J, Wang G, Shi M, et al.. BTK and YKL-40 levels and their association with acute AQP4-IgG-positive neuromyelitis optica spectrum disorder. Mol Neurobiol. 2025, 62:4785-801. 10.1007\/s12035-024-04588-5","journal-title":"Mol Neurobiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/477768-brainstem-encephalitis-with-conflicting-autoimmune-and-infectious-markers-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:29:31Z","timestamp":1777278571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/477768-brainstem-encephalitis-with-conflicting-autoimmune-and-infectious-markers-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.107784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}